HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$2.17
Day range
$2.08 - $2.25
Year range
$1.40 - $7.75
Market cap
57.28M USD
Avg Volume
142.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.38M | 41.67% |
Net income | -5.09M | -33.94% |
Net profit margin | — | — |
Earnings per share | -0.24 | 11.11% |
EBITDA | -5.37M | -41.61% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.51M | 30.31% |
Total assets | 19.93M | 33.65% |
Total liabilities | 3.72M | 112.88% |
Total equity | 16.20M | — |
Shares outstanding | 26.40M | — |
Price to book | 2.65 | — |
Return on assets | -63.39% | — |
Return on capital | -74.97% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.09M | -33.94% |
Cash from operations | -2.68M | 31.42% |
Cash from investing | -13.18K | — |
Cash from financing | 586.69K | 38.28% |
Net change in cash | -2.07M | 40.44% |
Free cash flow | -951.80K | 61.94% |
About
Founded
2012
Headquarters
Website
Employees
14